Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pituitary Macroadenoma”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableStudy completedNCT01471405
What this trial is testing

One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma

Who this might be right for
Acromegaly
Ipsen 54
Not applicableStudy completedNCT04074642
What this trial is testing

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

Who this might be right for
Pituitary Adenoma
Centre Hospitalier Universitaire de Nice 21
Early research (Phase 1)Study completedNCT04212793
What this trial is testing

Detection of PitNET Tissue During TSS Using Bevacizumab-800CW

Who this might be right for
Pituitary TumorPituitary AdenomaPituitary Macroadenoma
University Medical Center Groningen 20
Not applicableEnded earlyNCT02396810
What this trial is testing

Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas

Who this might be right for
Pituitary Macroadenoma
Dartmouth-Hitchcock Medical Center 10
Post-approval studies (Phase 4)Ended earlyNCT00242541
What this trial is testing

Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 50
Large-scale testing (Phase 3)Study completedNCT00690898
What this trial is testing

Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma

Who this might be right for
Acromegaly
Ipsen 108
Testing effectiveness (Phase 2)Study completedNCT00001860
What this trial is testing

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Who this might be right for
AcromegalyPituitary Neoplasm
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Not applicableStudy completedNCT03363126
What this trial is testing

Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma

Who this might be right for
Pituitary TumorOptic Chiasm Disorder
Fondation Ophtalmologique Adolphe de Rothschild 88
Not applicableUnknownNCT05149495
What this trial is testing

Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery

Who this might be right for
Acromegaly
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)WithdrawnNCT01203618
What this trial is testing

Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas

Who this might be right for
Resectable, Non-functioning Pituitary Adenoma
Morphotek
Testing effectiveness (Phase 2)Ended earlyNCT01444209
What this trial is testing

Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas

Who this might be right for
Pituitary Macroadenoma
University of Texas Southwestern Medical Center 2
Not applicableEnded earlyNCT04106531
What this trial is testing

Validation of a Quality of Life Metric "Prolac-10"

Who this might be right for
ProlactinomaProlactin-Producing Pituitary TumorPituitary Tumor+2 more
Ohio State University 8